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Abstract
Cinchona alkaloids with a free 6'-OH functionality are being increasingly used within asymmetric organocatalysis. This fascinating
class of bifunctional catalyst offers a genuine alternative to the more commonly used thiourea systems and because of the different
spacing between the functional groups, can control enantioselectivity where other organocatalysts have failed. In the main, this
review covers the highlights from the last five years and attempts to show the diversity of reactions that these systems can control.
It is hoped that chemists developing asymmetric methodologies will see the value in adding these easily accessible, but underused
organocatalysts to their screens.
Introduction
The cinchona alkaloids, comprising quinine (QN), quinidine
(QD), cinchonidine (CD), cinchonine (CN, Figure 1), and their
derivatives have revolutionized asymmetric catalysis owing to
their privileged structures. The functional groups within these
catalysts are highly pre-organized [1,2] and can both coordinate
to, and activate the components of a reaction in a well-defined
manner, thus facilitating a stereocontrolled process. The ability
to easily derivatise these catalyst systems in a bespoke fashion
in order to optimize their stereoselective behaviour has seen
their utility burgeon dramatically over the last decade. Of par-
ticular note is the use of these cinchona systems within bifunc-
tional thiourea catalysis [3-12].
Cupreine (CPN) and cupreidine (CPD), the non-natural
demethylated structures of quinine and quinidine, respectively,
have also found extensive utility, but not to the same extent,
which is surprising given the broad range of chemistries that
they have been shown to facilitate, and which are the subject of
this review.
Herein, we describe the highlights of CPN, CPD and their de-
rivatives in asymmetric organocatalysis over the last five years
or so [13,14]. The review is organized by reaction type, begin-
ning with the Morita–Baylis–Hillman process – one of the first
reactions to utilize 6’-OH-cinchona alkaloid derivatives in
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Figure 1: The structural diversity of the cinchona alkaloids, along with cupreine, cupreidine, β-isoquinidine and β-isocupreidine derivatives.
Scheme 1: The original 6’-OH cinchona alkaloid organocatalytic MBH process, showing how the free 6’-OH is essential for coordination to the
substrate.
asymmetric organocatalysis. The focus will then turn to asym-
metric 1,2-additions followed by conjugate additions, a cyclo-
propanation, (ep)oxidations, α-functionalisation processes,
cycloadditions, domino processes and finally miscellaneous
reactions. We ultimately aim to demonstrate through this
plethora of diverse processes, that the 6’-OH cinchona class of
alkaloids are a dynamic and versatile type of organocatalyst that
should be included in the screening libraries of chemists
seeking to develop asymmetric methodologies.
Review
Morita–Baylis–Hillman (MBH) and MBH-
carbonate reactions
The first reports of an asymmetric reaction catalyzed by a
cinchona organocatalyst with a 6’-OH functionality came from
Hatakeyama and co-workers in 1999 who demonstrated the use
of β-ICPD in an asymmetric Morita–Baylis–Hillman (MBH)
reaction [15-18] what is essentially an asymmetric C3-substi-
tuted ammonium enolate reaction (Scheme 1) [19,20]. In this
classic process, it was hypothesized that the 6’-OH group was
critical in directing the incoming aldehyde electrophile (see
Scheme 1 box).
Soon after, Shi and co-worker demonstrated the use of β-ICPD
in the reaction of imines 5 with methyl vinyl ketone (MVK, 6)
using the same catalyst (Scheme 2) [21]. The same study inves-
tigated methylacrylate and acrylonitrile as the conjugated
partner, but these were less successful. Shi proposed a similar
reaction mechanism for this process, whereby the 6’-OH func-
tionality is critical in the control of stereoselectivity.
In a more recent extension of this work, Shi, Li and co-workers
partnered the isatin derived N-Boc ketimines 8 with MVK (6,
Scheme 3a) to obtain the corresponding adducts 9 with very
Beilstein J. Org. Chem. 2016, 12, 429–443.
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Scheme 2: Use of β-ICPD in an aza-MBH reaction.
Scheme 3: (a) The isatin motif is a common feature for MBH processes catalyzed by β-ICPD, as demonstrated by Shi and Li and co-workers.
(b) Takizawa and co-workers demonstrated similar chemistry, but also utilized the catalyst α-ICPN (inset).
good selectivity [22]. Interestingly, replacing the Boc group
with an ethyl carbamate decreased the yield and enantioselectiv-
ity dramatically, as did having a substituent at the 4-position of
the ketimine. In a related study, Takizawa and co-workers
demonstrated that the quinine derived organocatalyst, α-ICPN
[23] produced the enantiomeric product in a similar process
using acrolein 10 as the conjugate partner (Scheme 3b) [24].
Chen and co-workers developed an aza-MBH process using
β-ICPD in the reaction between N-sulfonyl-1-aza-1,3-butadi-
enes and activated alkenes (Scheme 4) [25]. In this report,
optimal selectivity required (R)-BINOL as a co-catalyst (see
inset for proposed catalytic transition state – (R)-BINOL shown
in red). Furthermore, the utility of the adducts obtained was
demonstrated through their conversion to a number of useful
constructs (e.g., 16 and 17).
In reactions very much related to the MBH process, isatin deriv-
atives have also proven to be particularly suited to the reaction
of MBH-like products [26-28]. In these processes, the tertiary
amine adds into the conjugate ester as with the MBH reaction,
but instead of the resulting C3-ammonium enolate reacting with
an electrophile, an E1cB elimination of the carbonate occurs to
generate another conjugated system. This can then undergo an
attack by a Michael donor; elimination of the catalyst then
generates the exo-methylene adduct. For example, Lu and
co-workers have used β-ICPD to react isatin-derived MBH
carbonates 18 with nitroalkanes 19 [29]. The resulting adducts
20 could be converted to the corresponding spiroxindole 21 via
a Zn/HOAc mediated reduction of the nitro functionality
(Scheme 5).
Similarly, Kesavan and co-workers reacted 3-O-Boc-oxindoles
23 with MBH carbonates 22 to generate a range of spirocyclic
scaffolds containing α-exo-methylene-γ-butyrolactone 24 –
again using β-ICPD (Scheme 6) [30].
Nazarov cyclization
An asymmetric Nazarov cyclization has been developed by
Frontier and co-worker using β-ICPD through a mechanism
Beilstein J. Org. Chem. 2016, 12, 429–443.
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Scheme 4: (a) Chen’s asymmetric MBH reaction. Good selectivity was dependent upon the presence of (R)-BINOL (shown in red) as well as β-ICPD.
(b) Diverse structures were obtained from the MBH adduct 14a.
Scheme 5: Lu and co-workers synthesis of a spiroxindole.
that is reminiscent of the MBH reaction (Scheme 7) [31]. In this
process however, the tertiary amine adds to the conjugated
system 25 in a 1,6-fashion to generate intermediate enolate 26.
This undergoes a single bond rotation to set up a 4π-electrocy-
clization, generating second intermediate 27. Elimination of the
tertiary amine then gives γ-methylene cyclopentenone 28.
1,2-Addition reactions
Henry reaction
The use of cupreine and cupreidine derivatives in the addition
of nitroalkanes to carbonyl compounds was first demonstrated
by Deng and co-workers [32-34]. In this excellent study, cata-
lysts substituted with benzyl at the 9-OH position gave the best
Beilstein J. Org. Chem. 2016, 12, 429–443.
433
Scheme 6: Kesavan and co-workers’ synthesis of spiroxindoles.
Scheme 7: Frontier’s Nazarov cyclization catalyzed by β-ICPD.
Scheme 8: The first asymmetric nitroaldol process catalyzed by a 6’-OH cinchona alkaloid.
results (CPD-30, Scheme 8). This report also demonstrated that
the enantiomer of β-nitroester 31 could be obtained using the
corresponding pseudoenantiomeric organocatalyst with compa-
rable results.
More recently, Johnson and co-worker used the o-toluoyl
derived organocatalyst CPD-33 to effect a dynamic kinetic
asymmetric transformation of racemic β-bromo-α-keto esters 32
(Scheme 9a) [35]. The mechanism, deduced from deuterium
labeling studies, proposes that one of the two enantiomers of 32
will react more rapidly with nitromethane in the presence of the
cupreidine catalyst CPD-33. As these enantiomers equilibrate
via 35 in the presence of the catalyst, a dynamic kinetic asym-
metric reaction occurs (Scheme 9b).
Friedel–Crafts reaction
Pedro and co-workers have utilized a 9-OH benzoyl derivatised
cupreine CPN-38 to effect a Friedel-Crafts reaction of 2-naph-
thols 36 with benzoxathiazine 2,2-dioxides 37 (Scheme 10).
These cyclic imides, derived from salicylic aldehydes, have a
rigid structure which prevents E/Z-isomerization, allowing for
greater control over the stereochemical outcome of the reaction
[36]. This work was based on a related scheme from Chimni
and co-worker, who used CPN derivatised at the 9-OH
with 1-naphthoyl in the addition of sesamol to a range of
N-sulfonylimines [37].
1,4-Conjugate additions
Deng and co-workers have contributed many examples of 1,4-
additions that have been facilitated by CPD and CPN derived
catalysts. For example, and amongst the earliest examples in the
field, underivatized CPD or CPN were used in the addition of
dimethyl malonate (40) to a range of nitrostyrenes 41, giving
the resulting adducts with excellent enantioselectivity
(Scheme 11a) [38]. Subsequent reports by Deng and co-workers
include, amongst many varieties of Michael acceptor and donor
Beilstein J. Org. Chem. 2016, 12, 429–443.
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Scheme 9: A cupreidine derived catalyst induces a dynamic kinetic asymmetric transformation.
Scheme 10: Cupreine derivative 38 has been used in an organocatalytic asymmetric Friedel–Crafts reaction.
with various CPN/CPD derivatives [39-41], an example where
β-ketoesters are used as the nucleophilic component [42]. It is
on the basis of this work that Lin and co-workers were recently
inspired to use the (de-Me-DHQ)2PHAL catalyst HCPD-44 in
the addition of α-substituted nitro acetates 43 also into
nitroolefins 41 (Scheme 11b) [43-46].
Beilstein J. Org. Chem. 2016, 12, 429–443.
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Scheme 11: Examples of 6’-OH cinchona alkaloid catalyzed processes include: (a) Deng’s addition of dimethyl malonate into nitroolefins, and
(b) Lin’s similar process with α-nitroesters using the symmetric hydrocupreidine system HCPD-44.
Scheme 12: A diastereodivergent sulfa-Michael addition developed by Melchiorre and co-workers.
In a fascinating report, Melchiorre and co-workers use the
9-amino-CPD system CPD-48 to control the Michael addition
of thiols 46 into α-branched enones 47 via iminium ion cataly-
sis (Scheme 12) [47]. This study found that the catalytic func-
tion could be modulated to induce diastereodivergent pathways
by applying an external chemical stimulus (Scheme 12). Several
conclusions were made from this study, one of which was that
the hydrogen-bonding moiety of the 6’-OH in the catalyst is
essential in directing the reaction towards the anti-diastereose-
lective pathway. Secondly, the solvent was critical in the
diastereocontrol of the reaction. This is put down to the fact that
the solvent can have an important influence on the conforma-
tion of the flexible cinchona framework, which has a knock-on
effect on the catalytic outcome. Interestingly, the chiral nature
of the binol phosphoric acid catalyst (S)-49 in the anti-selective
process was not thought to be hugely influential upon the
stereochemical outcome. Indeed replacing it with diphenyl
hydrogen phosphate (DPP) gave comparable results, ultimately
Beilstein J. Org. Chem. 2016, 12, 429–443.
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Scheme 13: Melchiorre’s vinylogous Michael addition.
Scheme 14: Simpkins’s TKP conjugate addition reactions.
leading to a third conclusion – that the strong hydrogen-bond-
ing ability of the phosphate anion will favour the anti-selective
pathway.
Melchiorre and co-workers have also succeeded in using the
related cupreine organocatalyst CPN-51 in a direct vinylogous
Michael addition reaction [48]. In this process, cyclic enones 52
are added to nitroalkenes 41 using dienamine catalysis
(Scheme 13). Although no model is suggested with respect to
how the 6’-OH is involved, it is clearly of importance as the
analogous 6’-OMe derived cupreine catalyst gives significantly
lower conversions and selectivities.
Simpkins and co-workers have used CPD-30 in the reaction of
triketopiperidines (TKPs) 54 with a variety of enones with very
good selectivity (Scheme 14a) [49]. Interestingly, with differ-
ent types of acceptor, a cyclization event occurred leading to the
bicyclic hydroxydiketopiperizine system 56 with very high
diasterecontrol. Once again, the authors invoke a critical role
for the 6’-OH group in the co-ordination and activation of the
electrophile in these processes.
Cyclopropanations
Not unrelated to the Michael addition in a mechanistic sense, is
the asymmetric cyclopropanation using dimethyl bromoma-
lonate (57) and some form of Michael acceptor. In this process,
the enolate resulting from the initital conjugate addition attacks
the C–Br bond to form a three-membered ring. In our work in
this area, we designed a new cupreine derived catalyst HCPN-
59 to add dimethyl bromomalonate (57) to a conjugated
cyanosulfone 58 (Scheme 15). Our expectations were that the
highly functionalized adduct 60 that resulted would be able to
undergo a variety of chemistries, allowing access to a number
of diverse scaffolds. This was demonstrated through the synthe-
Beilstein J. Org. Chem. 2016, 12, 429–443.
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Scheme 15: Hydrocupreine catalyst HCPN-59 can be used in an asymmetric cyclopropanation.
sis of the corresponding 3-azabicyclo[3.1.0]hexane system 61
and the δ3-amino acid precursor 62 [50].
Epoxidations and oxaziridinations
A variety of cinchona-derived phase transfer catalysts have
been employed in the asymmetric epoxidation [51,52], but only
one utilizes the free 6’-OH. In this report by Berkessel and
co-workers, cupreine and cupreidine PTCs HCPN-65 and
HCPD-67 were used in the epoxidation of the cis-α,β-unsatu-
rated ketone 63 with sodium hypochlorite [53,54]. Interestingly,
the use of these pseudoenantiomers did not lead to similar mag-
nitudes of stereoselection in the opposite enantiomers of
epoxide 64 that they produced, as is often the case with
cinchona alkaloid catalyzed processes. However, the role of the
6’-OH was clearly important when directly compared with the
equivalent 6’-OiPr catalysts 66 and 68 (Scheme 16).
Jørgensen and co-workers have used another anthracenyl-modi-
fied hydrocupreidine HCPD-70 in an enantioselective oxazirid-
ination using mCPBA as the oxidant (Scheme 17) [55]. The
authors propose that the quinuclidine nitrogen is protonated by
the peracid, giving rise to a tight ion pair, whilst the 6’-OH co-
ordinates to the sulfonyl group oxygen, thus bringing the reac-
tants together. Subsequent reaction then leads to an intermedi-
ate α-aminoperoxy structure, which quickly collapses to the
oxaziridine 71.
Formation of C–X bonds α-functionalisation
In two separate reports, Zhou and co-workers demonstrate the
use of di-tert-butyl azodicarboxylate 72 (DBAD) in the direct
amination of several different substrates using β-isocupreidine
(β-ICPD). In the first of these, α-substituted nitoacetates 73 are
used [56], and in the second 3-thiooxindoles 75 are employed
(Scheme 18) [57]. Unfortunately, in neither of these papers is
the absolute stereochemistry elucidated.
Finally, Meng and co-workers used cupreidine (CPD) in the
α-hydroxylation of indenones (where n = 1 in 77) using cumyl
hydroperoxide (Scheme 19) [58]. Interestingly, the 3,4-dihy-
dronaphthalen-1(2H)-one derivative (where n = 2 in 77) did not
afford any detectable product.
Transamination
A range of α-amino acid derivatives have been accessed by Shi
and co-workers who developed an organocatalytic transamina-
tion process using the cupreine catalyst CPN-81, which is
substituted with n-butyl at the 9-OH position [59]. In this report,
the α-ketoester 79 was reacted with the primary amine
Beilstein J. Org. Chem. 2016, 12, 429–443.
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Scheme 16: The hydrocupreine and hydrocupreidine-based catalysts HCPN-65 and HCPD-67 demonstrate the potential for phase transfer catalyst
derivatives of the 6’-OH cinchona alkaloids to be used in asymmetric synthesis.
Scheme 17: Jørgensen’s oxaziridination.
Scheme 18: Zhou’s α-amination using β-ICPD.
Beilstein J. Org. Chem. 2016, 12, 429–443.
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Scheme 19: Meng’s cupreidine catalyzed α-hydroxylation.
Scheme 20: Shi’s biomimetic transamination process for the synthesis of α-amino acids.
o-ClC6H4CH2NH2 80 in the presence of the catalyst. Once
again, the role of the 6’-OH functionality is shown to be critical
in the orchestration of the reaction process, as depicted in the
proposed transition state model (Scheme 20).
Cycloadditions
The [4 + 2] cycloaddition of benzofuran-2(3H)-one derivatives
84 with methyl allenoate 85 to give the corresponding dihy-
dropyran fused benzofuran precursors 86 using β-ICPD has
been achieved by Li and Cheng and co-workers (Scheme 21a)
[60-63]. A large number of computational studies were con-
ducted to explain the enantioselection of the process, resulting
in the transition state shown which depicts a critical methanol
bridge, explaining the need for this as an additive within the
reaction to give optimal stereoselectivities. Similarly, Xu and
co-workers have used β-ICPD in the cycloaddition between
isatin framework 87 and olefinic azlactones 88 to give adduct
89 (Scheme 21b) [64].
Finally, in a remarkable demonstration of diversity-oriented
synthesis, Chen and co-workers have shown that simply by
switching the type of 6’-OH cinchona-derived catalyst used,
two different products can be obtained in their reaction be-
tween the 2-cyclohexenone MBH derivative 90 and isatylidene
malontirile 91, one of which is the [4 + 2] adduct 92, albeit
achieved in a step-wise manner (Scheme 21c) [65]. Disappoint-
Beilstein J. Org. Chem. 2016, 12, 429–443.
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Scheme 21: β-Isocupreidine catalyzed [4 + 2] cycloadditions.
ingly, though not uninteresting, is the fact that there is no enan-
tioinduction for either of these processes.
β-Isocupredeine has also been used in the [2 + 2]-addition be-
tween 2-thioxoacetates 94 and allenoates 95 to give the corre-
sponding thietanes 96. In another example of how a different
catalyst can lead to a different product, the authors demon-
strated that the use of DABCO led instead to the [4 + 2] adduct
(Scheme 22) [66].
Domino reaction
Although it could be argued that some of the reactions within
this review are already domino reactions (e.g., MBH, and the
cyclopropanation), a recent and clearer example of the use of a
6’-OH cinchona derived catalyst in such a process comes from
the laboratory of Samanta and co-workers [67,68]. They have
demonstrated an enantioselective domino reaction between
3-formylindoles 98 and nitroolefins 41 to generate the corre-
sponding tricyclic adducts 99 using cupreidine derivative CPD-
Beilstein J. Org. Chem. 2016, 12, 429–443.
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Scheme 22: β-Isocupreidine catalyzed [2+2] cycloaddition.
Scheme 23: A domino reaction catalyst by cupreidine catalyst CPD-30.
Scheme 24: (a) Dixon’s 6’-OH cinchona alkaloid catalyzed oxidative coupling. (b) An asymmetric oxidative coupling en route to the attempted total
synthesis of some amaryllidaceae alkaloids.
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30 (Scheme 23). Although the substrate scope for the enantiose-
lective reaction is limited, the diastereoselectivities are reason-
able, and the enantioselectivities are excellent.
Other processes
Asymmetric oxidative coupling
All carbon quaternary centers are prevalent in both natural and
pharmaceutical compounds, but rank amongst the hardest to
synthesize in a stereoselective manner. Dixon and co-workers
have addressed this through the development of an asymmetric
organocatalytic oxidative coupling – initially between
3-methoxycatechol (100) and tert-butyl 1-oxoindan-2-carboxyl-
ate (101) using an adamantane derivative of cupreidine CPD-
102 to give the corresponding adduct 103 in 84% yield and 81%
ee (Scheme 24a) [69]. An attempt to develop this methodology
towards an asymmetric total synthesis of buphanidrine (104)
and powelline (105) led to the bespoke development of another
cupreidine catalyst CPN-107. Unfortunately, although the re-
sulting adduct 108 (after alkylation of the catechol) was pro-
duced in a 70% enantiomeric excess (Scheme 24b), subsequent
steps that had worked with the racemic synthesis severely dete-
riorated this, preventing completion of the total synthesis
[70,71].
Conclusion
Cupreine and cupreidine and their derivatives have been
demonstrated to be suited to a wide range of reaction processes,
often with very good enantioinduction. In most cases these cata-
lysts are easy to make from the corresponding cinchona alka-
loids, making them attractive compounds for methodologists to
have within their catalyst arsenal. They seem particularly suited
to catalysis with systems that have an aromatic ring next to a
five-membered ring – e.g., indoles, indenones, isatin etc. –
especially when it comes to the Morita–Baylis–Hillman reac-
tion, although they are in no way limited to these, and one can
only expect the prevalence of these remarkable bifunctional
catalysts within the literature to increase over the coming years.
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